These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3951680)

  • 21. Effects of beta-endorphin2-9 on arginine-8-vasopressin and oxytocin levels in hypothalamic and limbic brain regions.
    Laczi F; Vecsernyés M; Kovács GL; Szabó G; Janáky T; Telegdy G; Lásló FA
    Brain Res; 1987 Feb; 403(1):155-7. PubMed ID: 3828809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasopressin maintains long-term potentiation in rat lateral septum slices.
    van den Hooff P; Urban IJ; de Wied D
    Brain Res; 1989 Dec; 505(2):181-6. PubMed ID: 2532055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential increase in Fos immunoreactivity in hypothalamic and septal nuclei by arginine8-vasopressin and desglycinamide9-arginine8-vasopressin.
    Lança AJ; Wu PH; Jung B; Liu JF; Ng V; Kalant H
    Neuroscience; 1999; 91(4):1331-41. PubMed ID: 10391440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of iontophoresis of vasopressin on lateral septal neurons.
    Marchand JE; Hagino N
    Exp Neurol; 1982 Dec; 78(3):790-5. PubMed ID: 7173382
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term facilitation of social recognition in rats by vasopressin related peptides: a structure-activity study.
    Popik P; Van Ree JM
    Life Sci; 1992; 50(8):567-72. PubMed ID: 1736027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemistry of vasopressin fragments.
    Burbach JP; Schoots O; Hernando F
    Prog Brain Res; 1998; 119():127-36. PubMed ID: 10074785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasopressin and oxytocin reduce plasma prolactin levels of conscious rats in basal and stress conditions. Study of the characteristics of the receptor involved.
    Mormede P; Vincent JD; Kerdelhue B
    Life Sci; 1986 Nov; 39(19):1737-43. PubMed ID: 3022094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The stimulation of Na+, K+-ATPase activity in the medulla of the rat kidney by [arginine] vasopressin and its analogues.
    Pippard C; Baylis PH
    Clin Sci (Lond); 1984 May; 66(5):561-7. PubMed ID: 6323092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A V1-type receptor for mediating the neurohypophysial hormone-induced ACTH release in trout pituitary.
    Pierson PM; Guibbolini ME; Lahlou B
    J Endocrinol; 1996 Apr; 149(1):109-15. PubMed ID: 8676042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agonist and antagonist specificities of decidual prostaglandin-releasing oxytocin receptors and myometrial uterotonic oxytocin receptors in pregnant rats.
    Chen DL; Chan WY; Manning M
    J Reprod Fertil; 1994 Nov; 102(2):337-43. PubMed ID: 7861386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasopressin neuropeptides and acquisition of heroin and cocaine self-administration in rats.
    van Ree JM; Burbach-Bloemarts EM; Wallace M
    Life Sci; 1988; 42(10):1091-9. PubMed ID: 3347140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An excitatory effect of vasopressin on neuronal firing in the hippocampus: structure-activity studies.
    Mühlethaler M; Dreifuss JJ
    Adv Biochem Psychopharmacol; 1982; 33():527-31. PubMed ID: 6896955
    [No Abstract]   [Full Text] [Related]  

  • 33. Similarities between hamster pancreatic islet beta (HIT) cell vasopressin receptors and V1b receptors.
    Richardson SB; Laya T; VanOoy M
    J Endocrinol; 1995 Oct; 147(1):59-65. PubMed ID: 7490538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vasopressin stimulates phosphatidylinositol turnover and aldosterone synthesis in rat adrenal glomerulosa cells: comparison with angiotensin II.
    Woodcock EA; Mcleod JK; Johnston CI
    Endocrinology; 1986 Jun; 118(6):2432-6. PubMed ID: 2938936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behaviorally active oxytocin fragments simultaneously attenuate heroin self-administration and tolerance in rats.
    Kovács CL; Van Ree JM
    Life Sci; 1985 Nov; 37(20):1895-900. PubMed ID: 4058258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasopressin and oxytocin. Their presence in the central nervous system and their functional significance in brain processes related to behaviour and memory.
    van Wimersma Greidanus TB; Burbach JP; Veldhuis HD
    Acta Endocrinol Suppl (Copenh); 1986; 276():85-94. PubMed ID: 3463110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteolytic conversion of oxytocin by brain synaptic membranes: role of aminopeptidases and endopeptidases.
    Stancampiano R; Melis MR; Argiolas A
    Peptides; 1991; 12(5):1119-25. PubMed ID: 1800950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasopressin and oxytocin modulation of melatonin secretion from rat pineal glands.
    Simonneaux V; Ouichou A; Burbach JP; Pévet P
    Peptides; 1990; 11(6):1075-9. PubMed ID: 2087432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine antagonism does not potentiate the effects of oxytocin and vasopressin on prolactin secretion.
    Pan JT; Mai LM
    Life Sci; 1990; 47(26):2443-50. PubMed ID: 2263168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.